Aclidinium is prescribed for:
- COPD maintenance treatment
- Chronic bronchitis
- Emphysema
- Respiratory bronchodilation
Provides long-acting bronchodilation via antimuscarinic action.
Generic Name: Aclidinium Bromide
Brand Names: Tudorza Pressair
Aclidinium is a twice-daily LAMA bronchodilator for long-term maintenance treatment of COPD.
Aclidinium is prescribed for:
Provides long-acting bronchodilation via antimuscarinic action.
Common side effects:
Serious side effects similar to other LAMAs (urinary retention, glaucoma worsening).
Aclidinium is a LAMA that's rapidly hydrolyzed in plasma, potentially reducing systemic side effects.
Unlike tiotropium (once daily), aclidinium is dosed twice daily, which may provide more consistent 24-hour coverage.
The Pressair device is breath-actuated, requiring less coordination than traditional MDIs.
For more information, see MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Aclidinium? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.